Literature DB >> 5038951

Type-specific and cross-reactive antibodies in gram-negative bacteremia.

W R McCabe, B E Kreger, M Johns.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5038951     DOI: 10.1056/NEJM197208102870601

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  48 in total

1.  Humoral immunity to gram-negative bacillary infections in experimental animals and man.

Authors:  W R McCabe
Journal:  Infection       Date:  1975       Impact factor: 3.553

2.  Delaying approval of a critical drug: safety, efficacy, economics, compassion.

Authors:  Leo T Rosenberg
Journal:  J Med Humanit       Date:  1994

3.  Passive immunization to outer membrane proteins MLP and PAL does not protect mice from sepsis.

Authors:  Catherine H Valentine; Judith Hellman; Laura K Beasley-Topliffe; Aranya Bagchi; H Shaw Warren
Journal:  Mol Med       Date:  2006 Sep-Oct       Impact factor: 6.354

4.  Wound infection during the Yom Kippur war: observations concerning antibiotic prophylaxis and therapy.

Authors:  R S Klein; S A Berger; P Yekutiel
Journal:  Ann Surg       Date:  1975-07       Impact factor: 12.969

5.  Opsonizing antibodies, host factors, and the limulus assay for endotoxin.

Authors:  L S Young
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

Review 6.  The birth pangs of monoclonal antibody therapeutics: the failure and legacy of Centoxin.

Authors:  Lara Marks
Journal:  MAbs       Date:  2012-04-26       Impact factor: 5.857

Review 7.  Immunoprophylaxis and immunotherapy of gram-negative sepsis and shock with antibodies to core glycolipids and lipid A of bacterial lipopolysaccharides.

Authors:  I G Mitov; D G Terziiski
Journal:  Infection       Date:  1991 Nov-Dec       Impact factor: 3.553

8.  A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance.

Authors:  J E Parrillo; C Burch; J H Shelhamer; M M Parker; C Natanson; W Schuette
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

9.  Phagocytic resistance of Escherichia coli K-1 isolates and relationship to virulence.

Authors:  R Weinstein; L S Young
Journal:  J Clin Microbiol       Date:  1978-12       Impact factor: 5.948

10.  Common enterobacterial antigen. 3. Initial titers and antibody response in bacteremia caused by gram-negative bacilli.

Authors:  W R McCabe; M Johns; T DiGenio
Journal:  Infect Immun       Date:  1973-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.